HUTCHMED (China) (HCM) Current Taxes (2014 - 2025)

HUTCHMED (China) (HCM) posted quarterly Current Taxes of $2.1 million for Q4 2025, up 87.32% quarter-over-quarter from $1.1 million in Q4 2022.

HUTCHMED (China) (HCM) Current Taxes (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has reported Current Taxes for 10 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.

In Q4 2025, Current Taxes changed N/A year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (changed N/A YoY), while the FY2025 annual figure was $2.1 million, changed N/A from the prior year.
Current Taxes climbed to $2.1 million in Q4 2025 per HCM's latest filing, from $1.1 million in the prior quarter.
Across five years, Current Taxes topped out at $15.5 million in Q4 2021 and bottomed at $1.1 million in Q4 2022.
Historically, Current Taxes has averaged $6.2 million across 3 years, with a median of $2.1 million in 2025.
Annual changes were most pronounced in 2021 — Current Taxes jumped 1288.04% — and 2022, when it sank 92.85%.
HUTCHMED (China)'s Current Taxes stood at $15.5 million in 2021, then tumbled by 92.85% to $1.1 million in 2022, then soared by 87.32% to $2.1 million in 2025.
Business Quant data shows HCM's Current Taxes at $2.1 million in Q4 2025, $1.1 million in Q4 2022, and $15.5 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-355.54 Mn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	138.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	739.89 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	46.00 Mn
10	HUTCHMED (China)	2.18 Bn	2.18 Bn	-	-

Download Data